nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Taste metallic—Metformin—polycystic ovary syndrome	0.0225	0.182	CcSEcCtD
Vidarabine—DPP4—embryo—polycystic ovary syndrome	0.02	0.0681	CbGeAlD
Vidarabine—ADK—adrenal cortex—polycystic ovary syndrome	0.0169	0.0575	CbGeAlD
Vidarabine—ADA—adipose tissue—polycystic ovary syndrome	0.0167	0.0567	CbGeAlD
Vidarabine—ADK—endometrium—polycystic ovary syndrome	0.0151	0.0514	CbGeAlD
Vidarabine—ADA—adrenal gland—polycystic ovary syndrome	0.0149	0.0508	CbGeAlD
Vidarabine—DPP4—endometrium—polycystic ovary syndrome	0.0146	0.0498	CbGeAlD
Vidarabine—ADA—vagina—polycystic ovary syndrome	0.0138	0.0471	CbGeAlD
Vidarabine—ADK—pituitary gland—polycystic ovary syndrome	0.0137	0.0465	CbGeAlD
Vidarabine—ADK—adipose tissue—polycystic ovary syndrome	0.0136	0.0463	CbGeAlD
Vidarabine—ADORA2A—adrenal gland—polycystic ovary syndrome	0.0136	0.0462	CbGeAlD
Vidarabine—DPP4—uterus—polycystic ovary syndrome	0.0135	0.0459	CbGeAlD
Vidarabine—DPP4—adipose tissue—polycystic ovary syndrome	0.0132	0.0449	CbGeAlD
Vidarabine—Clofarabine—RRM2—polycystic ovary syndrome	0.0132	0.635	CrCbGaD
Vidarabine—ADA—endocrine gland—polycystic ovary syndrome	0.013	0.0441	CbGeAlD
Vidarabine—ADK—adrenal gland—polycystic ovary syndrome	0.0122	0.0415	CbGeAlD
Vidarabine—DPP4—adrenal gland—polycystic ovary syndrome	0.0118	0.0403	CbGeAlD
Vidarabine—ADORA2A—endocrine gland—polycystic ovary syndrome	0.0118	0.0401	CbGeAlD
Vidarabine—ADK—female gonad—polycystic ovary syndrome	0.0114	0.0387	CbGeAlD
Vidarabine—ADK—vagina—polycystic ovary syndrome	0.0113	0.0385	CbGeAlD
Vidarabine—DPP4—female gonad—polycystic ovary syndrome	0.011	0.0375	CbGeAlD
Vidarabine—DPP4—vagina—polycystic ovary syndrome	0.011	0.0373	CbGeAlD
Vidarabine—ADK—endocrine gland—polycystic ovary syndrome	0.0106	0.036	CbGeAlD
Vidarabine—DPP4—endocrine gland—polycystic ovary syndrome	0.0103	0.0349	CbGeAlD
Vidarabine—Chest discomfort—Metformin—polycystic ovary syndrome	0.00807	0.0655	CcSEcCtD
Vidarabine—Cladribine—RRM2—polycystic ovary syndrome	0.00757	0.365	CrCbGaD
Vidarabine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00639	0.0519	CcSEcCtD
Vidarabine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00569	0.0462	CcSEcCtD
Vidarabine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0043	0.0349	CcSEcCtD
Vidarabine—Drowsiness—Metformin—polycystic ovary syndrome	0.004	0.0324	CcSEcCtD
Vidarabine—Bradycardia—Metformin—polycystic ovary syndrome	0.00365	0.0296	CcSEcCtD
Vidarabine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00357	0.029	CcSEcCtD
Vidarabine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00333	0.027	CcSEcCtD
Vidarabine—Flushing—Metformin—polycystic ovary syndrome	0.00333	0.027	CcSEcCtD
Vidarabine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00323	0.0262	CcSEcCtD
Vidarabine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00306	0.0248	CcSEcCtD
Vidarabine—Vision blurred—Metformin—polycystic ovary syndrome	0.00294	0.0239	CcSEcCtD
Vidarabine—Tremor—Metformin—polycystic ovary syndrome	0.00293	0.0237	CcSEcCtD
Vidarabine—Syncope—Metformin—polycystic ovary syndrome	0.0028	0.0227	CcSEcCtD
Vidarabine—Palpitations—Metformin—polycystic ovary syndrome	0.00276	0.0224	CcSEcCtD
Vidarabine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00274	0.0223	CcSEcCtD
Vidarabine—Hypertension—Metformin—polycystic ovary syndrome	0.0027	0.0219	CcSEcCtD
Vidarabine—Chest pain—Metformin—polycystic ovary syndrome	0.00266	0.0216	CcSEcCtD
Vidarabine—Discomfort—Metformin—polycystic ovary syndrome	0.00263	0.0213	CcSEcCtD
Vidarabine—Shock—Metformin—polycystic ovary syndrome	0.00251	0.0204	CcSEcCtD
Vidarabine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00246	0.02	CcSEcCtD
Vidarabine—Hypotension—Metformin—polycystic ovary syndrome	0.00238	0.0193	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00232	0.0188	CcSEcCtD
Vidarabine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00229	0.0186	CcSEcCtD
Vidarabine—ADK—Metabolism—NMNAT3—polycystic ovary syndrome	0.00229	0.00407	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00229	0.00407	CbGpPWpGaD
Vidarabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00227	0.0184	CcSEcCtD
Vidarabine—Somnolence—Metformin—polycystic ovary syndrome	0.00227	0.0184	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00225	0.004	CbGpPWpGaD
Vidarabine—ADA—p73 transcription factor network—SERPINE1—polycystic ovary syndrome	0.00224	0.00399	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00222	0.00396	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00218	0.00388	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00216	0.00384	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00216	0.00384	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00212	0.00376	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SUOX—polycystic ovary syndrome	0.00209	0.00372	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LPCAT2—polycystic ovary syndrome	0.00209	0.00372	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00208	0.00369	CbGpPWpGaD
Vidarabine—Urticaria—Metformin—polycystic ovary syndrome	0.00202	0.0164	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00202	0.00359	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00202	0.00359	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00198	0.00352	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00197	0.0035	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.00196	0.00349	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00196	0.00348	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ISYNA1—polycystic ovary syndrome	0.00194	0.00346	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00191	0.00339	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00186	0.00331	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00184	0.00328	CbGpPWpGaD
Vidarabine—Asthenia—Metformin—polycystic ovary syndrome	0.00183	0.0148	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00175	0.00311	CbGpPWpGaD
Vidarabine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.00174	0.00309	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF18—polycystic ovary syndrome	0.00169	0.003	CbGpPWpGaD
Vidarabine—Dizziness—Metformin—polycystic ovary syndrome	0.00169	0.0137	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00169	0.003	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKR1C2—polycystic ovary syndrome	0.00165	0.00294	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TEAD2—polycystic ovary syndrome	0.00165	0.00294	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00164	0.00293	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00164	0.00292	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00164	0.00292	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00162	0.00289	CbGpPWpGaD
Vidarabine—Vomiting—Metformin—polycystic ovary syndrome	0.00162	0.0132	CcSEcCtD
Vidarabine—Rash—Metformin—polycystic ovary syndrome	0.00161	0.013	CcSEcCtD
Vidarabine—Dermatitis—Metformin—polycystic ovary syndrome	0.00161	0.013	CcSEcCtD
Vidarabine—Headache—Metformin—polycystic ovary syndrome	0.0016	0.013	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00158	0.00281	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.00157	0.0028	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NMNAT3—polycystic ovary syndrome	0.00155	0.00276	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—GAB1—polycystic ovary syndrome	0.00154	0.00274	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00154	0.00273	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00154	0.00273	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00153	0.00272	CbGpPWpGaD
Vidarabine—Nausea—Metformin—polycystic ovary syndrome	0.00151	0.0123	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00149	0.00265	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.00146	0.0026	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00145	0.00258	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00144	0.00257	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00143	0.00255	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LPCAT2—polycystic ovary syndrome	0.00142	0.00253	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SUOX—polycystic ovary syndrome	0.00142	0.00253	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00139	0.00247	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00139	0.00247	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PNPLA2—polycystic ovary syndrome	0.00138	0.00246	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—TNRC6B—polycystic ovary syndrome	0.00138	0.00245	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00137	0.00244	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.00137	0.00244	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00135	0.00241	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00134	0.00239	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ISYNA1—polycystic ovary syndrome	0.00132	0.00235	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SRD5A1—polycystic ovary syndrome	0.00131	0.00234	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGF18—polycystic ovary syndrome	0.0013	0.00231	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00129	0.0023	CbGpPWpGaD
Vidarabine—ADK—Metabolism—STAR—polycystic ovary syndrome	0.00125	0.00223	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00125	0.00223	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00123	0.00218	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00121	0.00216	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ATF1—polycystic ovary syndrome	0.00121	0.00215	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0012	0.00214	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—GAB1—polycystic ovary syndrome	0.00118	0.00211	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00118	0.0021	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.00114	0.00202	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00114	0.00202	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TEAD2—polycystic ovary syndrome	0.00112	0.002	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKR1C2—polycystic ovary syndrome	0.00112	0.002	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMMR—polycystic ovary syndrome	0.00112	0.00199	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00111	0.00198	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.0011	0.00196	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HSD3B1—polycystic ovary syndrome	0.00106	0.00189	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00106	0.00189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—TNRC6B—polycystic ovary syndrome	0.00106	0.00188	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00106	0.00188	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00105	0.00186	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00102	0.00182	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.00101	0.0018	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00101	0.0018	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00101	0.00179	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000985	0.00175	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000985	0.00175	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000983	0.00175	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000982	0.00175	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00098	0.00174	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LHB—polycystic ovary syndrome	0.000971	0.00173	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HSD3B2—polycystic ovary syndrome	0.000949	0.00169	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000945	0.00168	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000943	0.00168	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PNPLA2—polycystic ovary syndrome	0.000941	0.00167	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000935	0.00166	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—ATF1—polycystic ovary syndrome	0.00093	0.00165	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000928	0.00165	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000928	0.00165	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKR1C1—polycystic ovary syndrome	0.000919	0.00164	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000913	0.00162	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRG1—polycystic ovary syndrome	0.000909	0.00162	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000907	0.00161	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000892	0.00159	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000876	0.00156	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000868	0.00154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NGFR—polycystic ovary syndrome	0.000858	0.00153	CbGpPWpGaD
Vidarabine—ADA—Metabolism—STAR—polycystic ovary syndrome	0.000851	0.00151	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SULT2A1—polycystic ovary syndrome	0.000846	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000843	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000843	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000843	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00082	0.00146	CbGpPWpGaD
Vidarabine—ADK—Metabolism—RRM2—polycystic ovary syndrome	0.000819	0.00146	CbGpPWpGaD
Vidarabine—ADK—Metabolism—YAP1—polycystic ovary syndrome	0.00079	0.0014	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000788	0.0014	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS2—polycystic ovary syndrome	0.000779	0.00139	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000777	0.00138	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000765	0.00136	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NAMPT—polycystic ovary syndrome	0.000759	0.00135	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMMR—polycystic ovary syndrome	0.000759	0.00135	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00075	0.00134	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP11A1—polycystic ovary syndrome	0.000749	0.00133	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000746	0.00133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000744	0.00132	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000724	0.00129	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKR1C3—polycystic ovary syndrome	0.000708	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NRG1—polycystic ovary syndrome	0.000699	0.00124	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP17A1—polycystic ovary syndrome	0.000697	0.00124	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00069	0.00123	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000682	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS1—polycystic ovary syndrome	0.00068	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000679	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000677	0.0012	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000677	0.0012	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LHB—polycystic ovary syndrome	0.00066	0.00117	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000645	0.00115	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT2—polycystic ovary syndrome	0.000629	0.00112	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000625	0.00111	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000621	0.00111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000617	0.0011	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—LEP—polycystic ovary syndrome	0.00061	0.00109	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00061	0.00109	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TH—polycystic ovary syndrome	0.000603	0.00107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IRS2—polycystic ovary syndrome	0.000599	0.00107	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000598	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000597	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000591	0.00105	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SLC2A4—polycystic ovary syndrome	0.000586	0.00104	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000578	0.00103	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000575	0.00102	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000571	0.00102	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000564	0.001	CbGpPWpGaD
Vidarabine—ADA—Metabolism—RRM2—polycystic ovary syndrome	0.000557	0.000991	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000554	0.000985	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP19A1—polycystic ovary syndrome	0.000551	0.000981	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000543	0.000966	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000539	0.00096	CbGpPWpGaD
Vidarabine—ADA—Metabolism—YAP1—polycystic ovary syndrome	0.000537	0.000955	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000537	0.000955	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00053	0.000943	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000528	0.00094	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000525	0.000933	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000524	0.000932	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IRS1—polycystic ovary syndrome	0.000523	0.00093	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—INS—polycystic ovary syndrome	0.000521	0.000927	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NAMPT—polycystic ovary syndrome	0.000516	0.000918	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000509	0.000906	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000505	0.000899	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000504	0.000897	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000503	0.000895	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000498	0.000886	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000498	0.000886	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GNAS—polycystic ovary syndrome	0.000492	0.000875	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT2—polycystic ovary syndrome	0.000484	0.000861	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000481	0.000856	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00048	0.000853	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000474	0.000842	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NCOR1—polycystic ovary syndrome	0.000469	0.000834	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000469	0.000834	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000466	0.000828	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000452	0.000804	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP1A1—polycystic ovary syndrome	0.000444	0.000791	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00044	0.000782	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000429	0.000762	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—polycystic ovary syndrome	0.000414	0.000737	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TH—polycystic ovary syndrome	0.00041	0.000729	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.0004	0.000712	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000399	0.000709	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00039	0.000694	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000375	0.000667	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000364	0.000648	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000357	0.000635	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000354	0.00063	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000343	0.00061	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—polycystic ovary syndrome	0.000336	0.000598	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNAS—polycystic ovary syndrome	0.000335	0.000595	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000333	0.000593	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—polycystic ovary syndrome	0.000331	0.000589	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INS—polycystic ovary syndrome	0.00033	0.000586	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000325	0.000578	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000323	0.000575	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000321	0.000571	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NCOR1—polycystic ovary syndrome	0.000319	0.000567	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000317	0.000564	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00031	0.000551	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000302	0.000537	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.0003	0.000534	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000299	0.000533	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000297	0.000528	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000293	0.000522	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00029	0.000516	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000285	0.000506	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000283	0.000504	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—polycystic ovary syndrome	0.000282	0.000501	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000279	0.000495	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000276	0.000491	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000272	0.000484	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000258	0.000459	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000254	0.000452	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000243	0.000433	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000231	0.000411	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—polycystic ovary syndrome	0.000228	0.000406	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000227	0.000405	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—polycystic ovary syndrome	0.000225	0.000401	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000225	0.0004	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INS—polycystic ovary syndrome	0.000224	0.000398	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—polycystic ovary syndrome	0.000219	0.000389	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000209	0.000372	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000209	0.000372	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000202	0.000359	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.0002	0.000355	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000195	0.000346	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000194	0.000345	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000184	0.000328	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000183	0.000326	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000183	0.000325	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000176	0.000313	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000173	0.000308	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000161	0.000286	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000153	0.000272	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00015	0.000267	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000129	0.000229	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000126	0.000224	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000112	0.0002	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000108	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INS—polycystic ovary syndrome	0.000108	0.000191	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000104	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000104	0.000185	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.88e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.96e-05	0.000142	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.8e-05	0.000121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—polycystic ovary syndrome	4.7e-05	8.36e-05	CbGpPWpGaD
